Chinese Regulator Probes Six Companies in IPO Fraud Crackdown
(Bloomberg) -- The China Securities Regulatory Commission said Friday it's investigating six companies over alleged wrongdoings related to initial public offerings and disclosures.
Longbao Ginseng & Antler Co., which is applying for a listing, is among the companies, the CSRC said in a statement posted on its official Weibo account. The five other companies, which have already gone public, are Guangdong Guangzhou Daily Media Co., Ingenious Ene-Carbon New Materials Co., Infotmic Co., P2P Financial Information Service Co. and Shenzhen Ecobeauty Co. The six are the fist batch of cases announced following the start of a CSRC enforcement campaign targeting IPO frauds.
Chinese regulators have stepped up supervision of IPOs this year. The regulator told brokerages in July to do better due diligence on prospective clients when arranging initial public offerings, secondary share sales and bond issues, people with direct knowledge of the matter said at the time, and vowed to punish rule breakers. The agency started a compulsory delisting of Dandong Xintai Electric Co. after finding the company gave false financial data in its 2011 IPO application, as well as annual and semi-annual reports from 2013 to 2014.
The CSRC will “persistently keep the high pressure” on IPO and information disclosure-related violations, it said in Friday's statement.
The alleged wrongdoings in the six cases include false representation in IPO prospectuses and fabrication of revenue and net income. The regulator will also go after intermediaries including underwriters, auditors and lawyers, it said in the statement.
To contact Bloomberg News staff for this story: Gary Gao in Shanghai at cgao58@bloomberg.net. To contact the editors responsible for this story: Sam Mamudi at smamudi@bloomberg.net, Ben Scent
With assistance from Gary Gao
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.